Ixekizumab

Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.[6][7] The most common side effects include upper respiratory infections, injection site reactions and fungal (tinea) infections.[8] The drug was developed by Eli Li... [wikipedia]